UroTech Surgical
Medical Equipment Manufacturing • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| SIC | 384 |
| Keywords | Bph - Benign Prostatic Hyperplasia, Kidney Stone Removal, Prostate Biopsy Technology |
| Employees | 1-10 |
Key Contact at UroTech Surgical
Thomas Hunter
Director
About UroTech Surgical
Medical Device Company - Preparing FDA 510K Application for Market Introduction. Urology and more specifically Benign Prostatic Hyperplasia (BPH) is a large market opportunity effecting over 500 Million Men globally. BPH surgical technology has not seen any significant advancements in how urologists treat patients suffering from BPH. UroTech Inc. was established to create innovative technologies that will enable urologists to quickly and easily treat BPH surgically while eliminating and or significantly reducing the negative side effects associated with older surgical techniques.
UroTech Surgical revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
UroTech Surgical has never raised funding before.
UroTech Surgical Tech Stack
Discover the technologies and tools that power UroTech Surgical's digital infrastructure, from frameworks to analytics platforms.
CDN
Miscellaneous
Security
Slovenia
Canada
Australia
United Arab Emirates
Belgium
Frequently asked questions
4.8
40,000 users
